catechin has been researched along with Cancer of Ovary in 37 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.70) | 18.7374 |
| 1990's | 1 (2.70) | 18.2507 |
| 2000's | 6 (16.22) | 29.6817 |
| 2010's | 24 (64.86) | 24.3611 |
| 2020's | 5 (13.51) | 2.80 |
| Authors | Studies |
|---|---|
| Acquaviva, A; Brunetti, L; Campana, C; Cesa, S; Chiavaroli, A; Di Simone, SC; Ferrante, C; Leone, S; Libero, ML; Menghini, L; Orlando, G; Recinella, L; Vitale, I; Zengin, G | 1 |
| Banerjee, A; Chanda, N; Chatterjee, M; Das, A; Maity, R; Mazumder, S; Mishra, R | 1 |
| Chen, X; Fu, M; Guan, X; Huang, F; Huangfu, M; Li, X; Liu, H; Qin, J; Wang, J; Yu, D | 1 |
| Annabi, B; Cappadocia, L; Sicard, AA; Suarez, NG | 1 |
| Chen, HY; Chiang, YF; Hsia, SM; Huang, YJ; Wang, KL | 1 |
| Bimonte, S; Cascella, M | 1 |
| Lei, C; Mu, Z; Mun, LY; Xinqiang, S | 1 |
| Ang, WX; Bae, KH; Chung, JE; Gao, SJ; Kurisawa, M; Tan, S; Wang, S; Yamashita, A | 1 |
| Chen, YC; Pan, H; Rankin, GO; Rojanasakul, Y; Tu, Y; Wang, F | 1 |
| Chen, YC; Kim, E; Pan, H; Rankin, GO; Rojanasakul, Y; Tu, Y | 1 |
| Kim, K; Kim, M; Kim, YB; Lee, S; No, JH; Park, WH; Suh, DH | 1 |
| Chen, YC; Gao, Y; Tu, Y; Yin, J | 1 |
| Li, J; Qiao, X; Tian, D; Tian, M; Zhang, L | 1 |
| Araya-Farias, M; Bachvarov, D; Bairati, I; Bazinet, L; Doyen, A; Duchesne, T; Grégoire, J; Labbé, DP; Plante, M; Renaud, MC; Têtu, B; Trudel, D | 1 |
| Chang, Z; Fan, Q; Wang, F; Wang, L | 1 |
| Feng, Q; Jiang, P; Wang, P; Wang, X; Yang, CS | 2 |
| Chen, YC; Gao, Y; Rankin, GO; Tu, Y | 2 |
| Chen, YC; Gao, Y; Kim, E; Li, B; Rankin, GO; Tu, Y | 1 |
| Khanna, A; Taparia, SS | 1 |
| Kalinovsky, T; Monterrey, JC; Niedzwiecki, A; Rath, M; Roomi, MW | 1 |
| Pagidas, K; Rao, SD | 1 |
| Beale, P; Huq, F; Yu, JQ; Yunos, NM | 1 |
| Butler, LM; Wu, AH | 1 |
| Chen, X; Shen, L; Yan, C; Yang, J | 1 |
| Bairati, I; Bazinet, L; Fradet, V; Labbé, DP; Têtu, B; Trudel, D | 1 |
| Beale, P; Chan, C; Huq, F; Mazumder, ME; Yu, JQ | 1 |
| Alvarez, RD; Chen, H; Landen, CN; Li, Y; Tollefsbol, TO | 1 |
| Ahn, WS; Bae, SM; Huh, SW; Kim, CK; Kim, SH; Kim, YW; Lee, IP; Lee, JM; Namkoong, SE | 1 |
| Chan, MM; Fong, D; Soprano, KJ; Weinstein, K | 1 |
| Wu, AH; Yu, MC | 1 |
| Albini, A; Bagnato, A; Decandia, S; Di Castro, V; Elia, G; Natali, PG; Rosanò, L; Spinella, F | 1 |
| Albini, A; Bagnato, A; Decandia, S; Di Castro, V; Natali, PG; Nicotra, MR; Rosanò, L; Spinella, F | 1 |
| Benghuzzi, H; Vance, S; Wilson-Simpson, F | 1 |
| Bast, A; Boven, E; Grimbergen, JA; Kramer, K; Kuiper, K; van Acker, SA; van den Berg, DJ; van der Vijgh, WJ | 1 |
| Bracke, M; Castronovo, V; Coopman, P; De Bruyne, G; Foidart, JM; Mareel, M | 1 |
5 review(s) available for catechin and Cancer of Ovary
| Article | Year |
|---|---|
Protective Effects of Epigallocatechin Gallate (EGCG) on Endometrial, Breast, and Ovarian Cancers.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Catechin; Endometrial Neoplasms; Epithelial-Mesenchymal Transition; Female; Humans; NF-E2-Related Factor 2; Ovarian Neoplasms; Protective Agents; Tea | 2020 |
The Potential Roles of Epigallocatechin-3-Gallate in the Treatment of Ovarian Cancer: Current State of Knowledge.
Topics: Antineoplastic Agents, Phytogenic; Catechin; Female; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Recurrence, Local; Ovarian Neoplasms | 2020 |
Green and black tea in relation to gynecologic cancers.
Topics: Alphapapillomavirus; Animals; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Antiviral Agents; Camellia sinensis; Catechin; Condylomata Acuminata; Endometrial Neoplasms; Female; Humans; Immunologic Factors; Ovarian Neoplasms; Papillomavirus Infections; Plant Leaves; Precancerous Conditions; Risk; Species Specificity; Tea; Uterine Cervical Neoplasms | 2011 |
Green tea for ovarian cancer prevention and treatment: a systematic review of the in vitro, in vivo and epidemiological studies.
Topics: Animals; Apoptosis; Carcinoma, Ovarian Epithelial; Catechin; Cell Line, Tumor; Cell Movement; Female; Humans; Incidence; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Protective Agents; Tea | 2012 |
Tea, hormone-related cancers and endogenous hormone levels.
Topics: Animals; Breast Neoplasms; Catechin; Female; Hormones; Humans; Male; Neoplasms; Ovarian Neoplasms; Prostatic Neoplasms; Risk Factors; Tea | 2006 |
1 trial(s) available for catechin and Cancer of Ovary
| Article | Year |
|---|---|
A two-stage, single-arm, phase II study of EGCG-enriched green tea drink as a maintenance therapy in women with advanced stage ovarian cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Endometrioid; Catechin; Combined Modality Therapy; Cystadenocarcinoma, Serous; Disease-Free Survival; Female; Humans; Maintenance Chemotherapy; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds; Ovarian Neoplasms; Taxoids; Tea | 2013 |
31 other study(ies) available for catechin and Cancer of Ovary
| Article | Year |
|---|---|
Protective Effects of PollenAid Plus Soft Gel Capsules' Hydroalcoholic Extract in Isolated Prostates and Ovaries Exposed to Lipopolysaccharide.
Topics: Anti-Inflammatory Agents; Antioxidants; Apoptosis; Catechin; Cell Line, Tumor; Chlorogenic Acid; Female; Humans; Interleukin-6; Lipopolysaccharides; Male; Ovarian Neoplasms; Phenols; Plant Extracts; Prostate; Prostatitis; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2022 |
Gold nanoparticle-assisted enhancement in the anti-cancer properties of theaflavin against human ovarian cancer cells.
Topics: Apoptosis; Biflavonoids; Biomarkers, Tumor; Catechin; Cell Line, Tumor; Cell Survival; Endocytosis; Female; Gold; Hemolysis; Humans; Membrane Potential, Mitochondrial; Metal Nanoparticles; Ovarian Neoplasms; Photoelectron Spectroscopy; Reactive Oxygen Species | 2019 |
PTEN/AKT/mTOR signaling mediates anticancer effects of epigallocatechin‑3‑gallate in ovarian cancer.
Topics: A549 Cells; Animals; Antineoplastic Agents, Phytogenic; Catechin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Ovarian Neoplasms; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Signal Transduction; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays | 2020 |
Functional targeting of the TGF-βR1 kinase domain and downstream signaling: A role for the galloyl moiety of green tea-derived catechins in ES-2 ovarian clear cell carcinoma.
Topics: Antineoplastic Agents, Phytogenic; Catechin; Cell Line, Tumor; Cell Movement; Female; Gallic Acid; Humans; Ovarian Neoplasms; Protein Kinase Inhibitors; Receptor, Transforming Growth Factor-beta Type I; Tea | 2021 |
Bioinformatics Analysis on Molecular Mechanism of Green Tea Compound Epigallocatechin-3-Gallate Against Ovarian Cancer.
Topics: Catechin; Computational Biology; Female; Gene Regulatory Networks; Humans; Ovarian Neoplasms; Protein Interaction Maps; Signal Transduction; Tea | 2017 |
Hyaluronic acid-green tea catechin micellar nanocomplexes: Fail-safe cisplatin nanomedicine for the treatment of ovarian cancer without off-target toxicity.
Topics: Animals; Antineoplastic Agents; Antioxidants; Apoptosis; Catechin; Cell Line, Tumor; Cell Survival; Cisplatin; Drug Carriers; Drug Liberation; Female; Humans; Hyaluronic Acid; Mice, SCID; Micelles; Nanoconjugates; Ovarian Neoplasms; Oxidative Stress; Particle Size; Surface Properties; Tea; Tissue Distribution | 2017 |
Inhibitory effect of black tea pigments, theaflavin‑3/3'-gallate against cisplatin-resistant ovarian cancer cells by inducing apoptosis and G1 cell cycle arrest.
Topics: Apoptosis; Biflavonoids; Catechin; Cell Line, Tumor; Cell Proliferation; Cisplatin; DNA Damage; Drug Resistance, Neoplasm; Female; Flow Cytometry; G1 Phase Cell Cycle Checkpoints; Gallic Acid; Humans; Mitogen-Activated Protein Kinase Kinases; Oncogene Protein v-akt; Ovarian Neoplasms; Signal Transduction; Tea | 2017 |
Theaflavin-3,3'-Digallate Enhances the Inhibitory Effect of Cisplatin by Regulating the Copper Transporter 1 and Glutathione in Human Ovarian Cancer Cells.
Topics: Biflavonoids; Catechin; Cation Transport Proteins; Cell Line, Tumor; Cisplatin; Copper Transporter 1; DNA Adducts; DNA Damage; Drug Synergism; Female; Glutathione; Humans; Ovarian Neoplasms; Up-Regulation | 2018 |
Oligonol, a Low Molecular Weight Polyphenol, Enhances Apoptotic Cell Death in Ovarian Cancer Cells via Suppressing NF-κB Activation.
Topics: Apoptosis; Catechin; Cell Line, Tumor; Cell Survival; Female; Humans; NF-kappa B; Ovarian Neoplasms; Phenols; Reactive Oxygen Species; Signal Transduction | 2019 |
Theaflavin-3,3'-Digallate Suppresses Human Ovarian Carcinoma OVCAR-3 Cells by Regulating the Checkpoint Kinase 2 and p27 kip1 Pathways.
Topics: Antioxidants; Apoptosis; Biflavonoids; Camellia sinensis; Carcinoma; Catechin; Cell Line, Tumor; Checkpoint Kinase 2; Cyclin-Dependent Kinase Inhibitor p27; Female; Gene Expression Regulation, Neoplastic; Humans; Ovarian Neoplasms; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; Tea; Tumor Suppressor Protein p53 | 2019 |
Modulation of Myb-induced NF-kB -STAT3 signaling and resulting cisplatin resistance in ovarian cancer by dietary factors.
Topics: Antineoplastic Agents; Catechin; Cell Proliferation; Cisplatin; Curcumin; Drug Resistance, Neoplasm; Female; Humans; Isothiocyanates; NF-kappa B; Ovarian Neoplasms; Proto-Oncogene Proteins c-myb; Signal Transduction; STAT3 Transcription Factor; Sulfoxides | 2019 |
Epigallocatechin‑3‑gallate inhibits the proliferation and migration of human ovarian carcinoma cells by modulating p38 kinase and matrix metalloproteinase‑2.
Topics: Anticarcinogenic Agents; Carcinoma; Catechin; Cell Line, Tumor; Cell Movement; Cell Proliferation; Enzyme Activation; Female; Humans; Imidazoles; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Ovarian Neoplasms; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Biosynthesis; Pyridines | 2014 |
EGCG Enhances Cisplatin Sensitivity by Regulating Expression of the Copper and Cisplatin Influx Transporter CTR1 in Ovary Cancer.
Topics: Animals; Catechin; Cation Transport Proteins; Cell Line, Tumor; Cisplatin; Copper Transporter 1; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Ovarian Neoplasms; Xenograft Model Antitumor Assays | 2015 |
Correction: EGCG Enhances Cisplatin Sensitivity by Regulating Expression of the Copper and Cisplatin Influx Transporter CTR1 in Ovary Cancer.
Topics: Antineoplastic Agents; Catechin; Cation Transport Proteins; Cisplatin; Copper Transporter 1; Female; Humans; Ovarian Neoplasms | 2015 |
Theaflavin-3, 3'-digallate decreases human ovarian carcinoma OVCAR-3 cell-induced angiogenesis via Akt and Notch-1 pathways, not via MAPK pathways.
Topics: Biflavonoids; Carcinoma; Catechin; Cell Line, Tumor; Female; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mitogen-Activated Protein Kinase Kinases; Neovascularization, Pathologic; Oncogene Protein v-akt; Ovarian Neoplasms; Proto-Oncogene Proteins c-myc; Receptor, Notch1; Signal Transduction; Vascular Endothelial Growth Factor A | 2016 |
Inhibitory Effects of the Four Main Theaflavin Derivatives Found in Black Tea on Ovarian Cancer Cells.
Topics: Antineoplastic Agents; Antioxidants; Apoptosis; Biflavonoids; Blotting, Western; Catechin; Cell Proliferation; Cells, Cultured; Female; Human Umbilical Vein Endothelial Cells; Humans; Ovarian Neoplasms; Tea | 2016 |
Theaflavin-3, 3'-digallate induces apoptosis and G2 cell cycle arrest through the Akt/MDM2/p53 pathway in cisplatin-resistant ovarian cancer A2780/CP70 cells.
Topics: Apoptosis; Biflavonoids; Catechin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Drug Resistance, Neoplasm; Female; G2 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Humans; Ovarian Neoplasms; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-mdm2; Signal Transduction; Tumor Suppressor Protein p53 | 2016 |
Procyanidin-rich extract of natural cocoa powder causes ROS-mediated caspase-3 dependent apoptosis and reduction of pro-MMP-2 in epithelial ovarian carcinoma cell lines.
Topics: Apoptosis; Biflavonoids; Blotting, Western; Cacao; Carcinoma, Ovarian Epithelial; Caspase 3; Catechin; Cell Line, Tumor; Cell Nucleus; Cell Shape; Female; Humans; Intracellular Space; Matrix Metalloproteinase 2; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Plant Extracts; Powders; Proanthocyanidins; Reactive Oxygen Species | 2016 |
In vitro modulation of MMP-2 and MMP-9 in human cervical and ovarian cancer cell lines by cytokines, inducers and inhibitors.
Topics: Catechin; Cell Line, Tumor; Cytokines; Dose-Response Relationship, Drug; Doxycycline; Enzyme Induction; Female; Humans; Interleukin-1beta; Lipopolysaccharides; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Ovarian Neoplasms; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha; Uterine Cervical Neoplasms | 2010 |
Epigallocatechin-3-gallate, a natural polyphenol, inhibits cell proliferation and induces apoptosis in human ovarian cancer cells.
Topics: Anticarcinogenic Agents; Apoptosis; Catechin; Cell Cycle; Cell Growth Processes; Cell Line, Tumor; Cell Survival; DNA, Neoplasm; Dose-Response Relationship, Drug; Female; Humans; In Situ Nick-End Labeling; Ovarian Neoplasms | 2010 |
Synergism from sequenced combinations of curcumin and epigallocatechin-3-gallate with cisplatin in the killing of human ovarian cancer cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Catechin; Cisplatin; Curcumin; DNA Adducts; Drug Synergism; Female; Humans; Ovarian Neoplasms; Tumor Cells, Cultured | 2011 |
Inhibitory effect of Epigallocatechin gallate on ovarian cancer cell proliferation associated with aquaporin 5 expression.
Topics: Analysis of Variance; Anticarcinogenic Agents; Antioxidants; Apoptosis; Aquaporin 5; Catechin; Cell Line, Tumor; Cell Membrane; Cell Nucleus; Cell Proliferation; Cytoplasm; Dose-Response Relationship, Drug; Down-Regulation; Female; Humans; I-kappa B Proteins; NF-KappaB Inhibitor alpha; Ovarian Neoplasms; Pyrrolidines; RNA, Messenger; Thiocarbamates; Transcription Factor RelA | 2012 |
Epigallocatechin gallate acts synergistically in combination with cisplatin and designed trans-palladiums in ovarian cancer cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ovarian Epithelial; Catechin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; DNA Adducts; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Palladium | 2012 |
Epigallocatechin gallate and sulforaphane combination treatment induce apoptosis in paclitaxel-resistant ovarian cancer cells through hTERT and Bcl-2 down-regulation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Catechin; Cell Cycle; Cell Proliferation; Down-Regulation; Drug Resistance, Neoplasm; Female; Humans; Isothiocyanates; Ovarian Neoplasms; Paclitaxel; Proto-Oncogene Proteins c-bcl-2; Sulfoxides; Telomerase; Thiocyanates; Tumor Cells, Cultured | 2013 |
Anticancer effects of (-)-epigallocatechin-3-gallate on ovarian carcinoma cell lines.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Catechin; Cdc20 Proteins; Cell Cycle; Cell Cycle Proteins; Cell Division; Cell Line, Tumor; Cyclin A; Cyclin B; Cyclin B1; Dose-Response Relationship, Drug; Female; Humans; Ovarian Neoplasms; RNA, Messenger | 2004 |
Epigallocatechin-3-gallate delivers hydrogen peroxide to induce death of ovarian cancer cells and enhances their cisplatin susceptibility.
Topics: Antineoplastic Agents; Antioxidants; Catechin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Cyclic N-Oxides; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Synergism; Female; Fluoresceins; Humans; Hydrogen Peroxide; Ovarian Neoplasms; Pyruvic Acid; Spin Labels | 2006 |
Antitumor effect of green tea polyphenol epigallocatechin-3-gallate in ovarian carcinoma cells: evidence for the endothelin-1 as a potential target.
Topics: Antineoplastic Agents; Catechin; Cell Line, Tumor; Cyclooxygenase Inhibitors; Dinoprostone; Endothelin A Receptor Antagonists; Endothelin-1; Female; Humans; Ovarian Neoplasms; Promoter Regions, Genetic; RNA, Messenger; Tea | 2006 |
Green tea polyphenol epigallocatechin-3-gallate inhibits the endothelin axis and downstream signaling pathways in ovarian carcinoma.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; bcl-X Protein; Caspase 3; Caspases; Catechin; Cell Proliferation; Endothelin-1; Enzyme Activation; Female; Humans; Mice; Mice, Nude; Mitogen-Activated Protein Kinases; Neoplasm Invasiveness; Ovarian Neoplasms; Phosphatidylinositol 3-Kinases; Receptor, Endothelin A; Signal Transduction; Tea; Transplantation, Heterologous; Urokinase-Type Plasminogen Activator; Vascular Endothelial Growth Factor A | 2006 |
Physiological responses of ES-2 ovarian cell line following administration of epigallocatechin-3-gallate (EGCG), thymoquinone (TQ), and selenium (SE).
Topics: Antineoplastic Agents; Antioxidants; Benzoquinones; Catechin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Neoplasm Proteins; Ovarian Neoplasms; Selenium | 2007 |
Monohydroxyethylrutoside, a dose-dependent cardioprotective agent, does not affect the antitumor activity of doxorubicin.
Topics: Animals; Antibiotics, Antineoplastic; Antioxidants; Breast Neoplasms; Cardiomyopathies; Catechin; Chelation Therapy; Cystadenocarcinoma, Serous; Dose-Response Relationship, Drug; Doxorubicin; Drug Interactions; Electrocardiography; Female; Flavonoids; Flavonols; Free Radical Scavengers; Free Radicals; Humans; Hydroxyethylrutoside; Iron; Iron Chelating Agents; Kaempferols; Mice; Mice, Nude; Molecular Structure; Neoplasm Transplantation; Ovarian Neoplasms; Quercetin; Razoxane; Rutin; Telemetry; Tumor Cells, Cultured; Weight Loss | 1997 |
Interactions of invasive cells with native and modified extracellular matrix in vitro.
Topics: Animals; Catechin; Cell Adhesion; Cell Division; Extracellular Matrix; Female; Laminin; Lymphoma, Large B-Cell, Diffuse; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Neoplasm Invasiveness; Neoplasm Metastasis; Ovarian Neoplasms | 1988 |